ACADL (acyl-CoA dehydrogenase long chain)

2014-11-01  

Identity

HGNC
LOCATION
2q34
LOCUSID
ALIAS
ACAD4,LCAD
FUSION GENES

Other Information

Locus ID:

NCBI: 33
MIM: 609576
HGNC: 88
Ensembl: ENSG00000115361

Variants:

dbSNP: 33
ClinVar: 33
TCGA: ENSG00000115361
COSMIC: ACADL

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000115361ENST00000233710P28330

Expression (GTEx)

0
10
20
30
40
50
60
70

Pathways

PathwaySourceExternal ID
Fatty acid degradationKEGGko00071
PPAR signaling pathwayKEGGko03320
Fatty acid degradationKEGGhsa00071
PPAR signaling pathwayKEGGhsa03320
Metabolic pathwaysKEGGhsa01100
beta-OxidationKEGGhsa_M00087
beta-OxidationKEGGM00087
Fatty acid metabolismKEGGhsa01212
Fatty acid metabolismKEGGko01212
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Fatty acid, triacylglycerol, and ketone body metabolismREACTOMER-HSA-535734
Mitochondrial Fatty Acid Beta-OxidationREACTOMER-HSA-77289
mitochondrial fatty acid beta-oxidation of saturated fatty acidsREACTOMER-HSA-77286
Beta oxidation of myristoyl-CoA to lauroyl-CoAREACTOMER-HSA-77285
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoAREACTOMER-HSA-77310
mitochondrial fatty acid beta-oxidation of unsaturated fatty acidsREACTOMER-HSA-77288

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
369294662023ACADL suppresses PD-L1 expression to prevent cancer immune evasion by targeting Hippo/YAP signaling in lung adenocarcinoma.6
371518792023Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma.9
369294662023ACADL suppresses PD-L1 expression to prevent cancer immune evasion by targeting Hippo/YAP signaling in lung adenocarcinoma.6
371518792023Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma.9
336104712021Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months.3
336104712021Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months.3
323895752020The common K333Q polymorphism in long-chain acyl-CoA dehydrogenase (LCAD) reduces enzyme stability and function.6
323895752020The common K333Q polymorphism in long-chain acyl-CoA dehydrogenase (LCAD) reduces enzyme stability and function.6
312340152019The fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase can be a source of mitochondrial hydrogen peroxide.24
312340152019The fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase can be a source of mitochondrial hydrogen peroxide.24
245915162014Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction.30
245915162014Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction.30
241215002013Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site.87
241215002013Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site.87
200375892010A genome-wide perspective of genetic variation in human metabolism.323

Citation

Dessen P

ACADL (acyl-CoA dehydrogenase long chain)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/60072/haematological-explorer/favicon/favicon-32x32.png